Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDT

NCT05820100 · clinicaltrials.gov ↗

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinitis Pigmentosa
Retinal Dystrophy

Interventions

OTHER: Observational

Sponsor

Nanoscope Therapeutics Inc.